Brca2 deficiency sensitizes cells to PARP inhibition [Correction to Hay et al. 65 (22): 10145]

Hay, T., Jenkins, H., Sansom, O. J., Martin, N. M. B., Smith, G. C. M. and Clarke, Alan Richard ORCID: https://orcid.org/0000-0002-4281-426X 2006. Brca2 deficiency sensitizes cells to PARP inhibition [Correction to Hay et al. 65 (22): 10145]. Cancer Research 66 (1) , p. 599. 10.1158/0008-5472.CAN-66-1-COR

Full text not available from this repository.

Abstract

In the article on how Brca2 deficiency sensitizes cells to PARP inhibition in the November 15, 2005 issue of Cancer Research ( 1), the grant support in the Acknowledgment should have read as follows: Association for International Cancer Research grant no. 03–336, KuDOS Pharmaceuticals Ltd., and Wales Gene Park.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Biosciences European Cancer Stem Cell Research Institute (ECSCRI)
Subjects:	R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Publisher:	American Association for Cancer Research
ISSN:	0008-5472
Last Modified:	28 Oct 2022 08:28
URI:	https://orca.cardiff.ac.uk/id/eprint/70919

Actions (repository staff only)

Edit Item